Search research articles
Contact Us
Filters
Showing results (451-460 of 554) with videos related to
Page
of 56
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 2017
Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease
Robert J Andrew, Celia G Fernandez, Molly Stanley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 15, 2018
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R Jack, David A Bennett, Kaj Blennow, et al.
Nature Medicine
|
March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
Kanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
Plos One
|
January 26, 2011
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease
Richard J Perrin, Rebecca Craig-Schapiro, James P Malone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease
Rosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Biological Psychiatry
|
November 2, 2010
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease
Rebecca Craig-Schapiro, Richard J Perrin, Catherine M Roe, et al.
Annals of Neurology
|
June 18, 2011
Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction
Saori Hata, Sayaka Fujishige, Yoichi Araki, et al.
Neurology. Genetics
|
April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
Suzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Cell
|
August 13, 2017
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease
Tyler K Ulland, Wilbur M Song, Stanley Ching-Cheng Huang, et al.
Page
of 56
Search research articles
Search
Showing results (451-460 of 554) with videos related to
Sort By:
Page
of 56
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 2017
Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease
Robert J Andrew, Celia G Fernandez, Molly Stanley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 15, 2018
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R Jack, David A Bennett, Kaj Blennow, et al.
Nature Medicine
|
March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
Kanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
Plos One
|
January 26, 2011
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease
Richard J Perrin, Rebecca Craig-Schapiro, James P Malone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease
Rosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Biological Psychiatry
|
November 2, 2010
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease
Rebecca Craig-Schapiro, Richard J Perrin, Catherine M Roe, et al.
Annals of Neurology
|
June 18, 2011
Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction
Saori Hata, Sayaka Fujishige, Yoichi Araki, et al.
Neurology. Genetics
|
April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
Suzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Cell
|
August 13, 2017
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease
Tyler K Ulland, Wilbur M Song, Stanley Ching-Cheng Huang, et al.
Page
of 56